Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation

A deficit in glucose uptake and a deposition of amyloid β-peptide (Aβ) each occur in vulnerable brain regions in Alzheimer’s disease (AD). It is not known whether mechanistic links exist between Aβ deposition and impaired glucose transport. We now report that Aβ impairs glucose transport in cultured rat hippocampal and cortical neurons by a mechanism involving membrane lipid peroxidation. Aβ impaired 3H-deoxy-glucose transport in a concentration-dependent manner and with a time course preceding neurodegeneration. The decrease in glucose transport was followed by a decrease in cellular ATP levels. Impairment of glucose transport, ATP depletion, and cell death were each prevented in cultures pretreated with antioxidants. Exposure to FeSO4, an established inducer of lipid peroxidation, also impaired glucose transport. Immunoprecipitation and Western blot analyses showed that exposure of cultures to Aβ induced conjugation of 4-hydroxynonenal (HNE), an aldehydic product of lipid peroxidation, to the neuronal glucose transport protein GLUT3. HNE induced a concentration-dependent impairment of glucose transport and subsequent ATP depletion. Impaired glucose transport was not caused by a decreased energy demand in the neurons, because ouabain, which inhibits Na+/K+-ATPase activity and thereby reduces neuronal ATP hydrolysis rate, had little or no effect on glucose transport. Collectively, the data demonstrate that lipid peroxidation mediates Aβ-induced impairment of glucose transport in neurons and suggest that this action of Aβ may contribute to decreased glucose uptake and neuronal degeneration in AD.

[1]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[2]  A. Young,et al.  Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.

[3]  A. Novelli,et al.  Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced , 1988, Brain Research.

[4]  M. Mattson,et al.  Basic FGF, NGF, and IGFs Protect Hippocampal and Cortical Neurons against Iron-Induced Degeneration , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  W. Markesbery,et al.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  W. D. Ehmann,et al.  Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease , 1995, Neurology.

[7]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Butterfield,et al.  Amyloid β Peptide (25–35) Inhibits Na+‐Dependent Glutamate Uptake in Rat Hippocampal Astrocyte Cultures , 1996, Journal of neurochemistry.

[9]  R Luft,et al.  The development of mitochondrial medicine. , 1995, Biochimica et biophysica acta.

[10]  G. Benzi,et al.  Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. , 1995, Free radical biology & medicine.

[11]  M. Mattson,et al.  Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology , 1995, Neurobiology of Aging.

[12]  D. Selkoe The molecular pathology of Alzheimer's disease , 1991, Neuron.

[13]  T. Montine,et al.  E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. , 1996, The American journal of pathology.

[14]  M. Mattson,et al.  4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes , 1997, Neuroscience.

[15]  I. Simpson,et al.  Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons. , 1996, The Biochemical journal.

[16]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[17]  Takesue Yoshiki,et al.  Effect of phloretin on na+-dependent d-glucose uptake by intestinal brush border membrane vesicles , 1983 .

[18]  R. Rydel,et al.  Amyloid β‐Mediated Oxidative and Metabolic Stress in Rat Cortical Neurons: No Direct Evidence for a Role for H2O2 Generation , 1996, Journal of neurochemistry.

[19]  F. Crawford,et al.  Genetic and molecular advances in Alzheimer's disease. , 1993, Trends in neurosciences.

[20]  M. Brines,et al.  The cardiac glycoside ouabain potentiates excitotoxic injury of adult neurons in rat hippocampus , 1995, Neuroscience Letters.

[21]  J. Blass Metabolic alterations common to neural and non‐neural cells in alzheimer's disease , 1993, Hippocampus.

[22]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  H. Thaler,et al.  Expression in cultured human neuroblastoma cells of epitopes associated with affected neurons in Alzheimer's disease. , 1990, The American journal of pathology.

[24]  M. Beal,et al.  Bioenergetic and oxidative stress in neurodegenerative diseases. , 1995, Life sciences.

[25]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  M. Mattson,et al.  Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Sapolsky,et al.  Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. , 1990, Neuroendocrinology.

[28]  Richard S. J. Frackowiak,et al.  Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.

[29]  M. Mattson,et al.  Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF , 1993, Brain Research.

[30]  G. Perry,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Hyman,et al.  Functional Alterations in Alzheimer's Disease: Decreased Glucose Transporter 3 Immunoreactivity in the Perforant Pathway Terminal Zone , 1995, Journal of neuropathology and experimental neurology.

[32]  M. Mattson,et al.  Metyrapone, an Inhibitor of Glucocorticoid Production, Reduces Brain Injury Induced by Focal and Global Ischemia and Seizures , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  M. Mattson,et al.  β-Amyloid Peptide Free Radical Fragments Initiate Synaptosomal Lipoperoxidation in a Sequence-Specific Fashion: Implications to Alzheimer′s Disease , 1994 .

[34]  M. Mullan,et al.  Genetics and molecular advances in Alzheimer's disease , 1993, Trends in Neurosciences.

[35]  M. Alaiz,et al.  Modification of histidine residues by 4,5-epoxy-2-alkenals. , 1999, Chemical Research in Toxicology.

[36]  S. Younkin,et al.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. , 1994, Science.

[37]  M. Mattson,et al.  Growth Factors Prevent Mitochondrial Dysfunction, Loss of Calcium Homeostasis, and Cell Injury, but Not ATP Depletion in Hippocampal Neurons Deprived of Glucose , 1993, Experimental Neurology.

[38]  I. Simpson,et al.  Modulation of Expression of Glucose Transporters GLUT3 and GLUT1 by Potassium and N-Methyl-d-aspartate in Cultured Cerebellar Granule Neurons , 1994, Molecular and Cellular Neuroscience.

[39]  D E Kuhl,et al.  Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[41]  M. Mattson,et al.  Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF , 1992, Experimental Neurology.

[42]  J. Pettegrew,et al.  Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.

[43]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[44]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[45]  R N Kalaria,et al.  Reduced Glucose Transporter at the Blood‐Brain Barrier and in Cerebral Cortex in Alzheimer Disease , 1989, Journal of neurochemistry.

[46]  M. Mattson,et al.  Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. , 1994, Experimental neurology.

[47]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[48]  M. Mattson,et al.  Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor , 1996 .

[49]  M. Mattson,et al.  Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. , 1995, Methods in cell biology.

[50]  M. Mattson,et al.  Secreted Forms of β-Amyloid Precursor Protein Protect Hippocampal Neurons against Amyloid β-Peptide-Induced Oxidative Injury , 1994, Experimental Neurology.

[51]  N. Sims Altered glucose metabolism in Alzheimer's disease , 1990, Annals of neurology.

[52]  E. Stadtman,et al.  Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[55]  D. Selkoe,et al.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. , 1992, Nature.

[56]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[57]  W. Honer,et al.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease , 1994, Annals of neurology.

[58]  M. Mattson,et al.  Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. , 1996, Brain research. Molecular brain research.

[59]  E. Stadtman,et al.  Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[61]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[62]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[63]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[64]  P. Calabresi,et al.  Vulnerability of Medium Spiny Striatal Neurons to Glutamate: Role of Na+/K+ ATPase , 1995, The European journal of neuroscience.

[65]  F. V. van Kuijk,et al.  4-hydroxynonenal inhibits Na(+)-K(+)-ATPase. , 1996, Free radical biology & medicine.

[66]  M. Mattson Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and Ca2+ influx in cultured hippocampal neurons , 1990, Neuron.

[67]  P. May,et al.  β-amyloid peptide in vitro toxicity: Lot-to-lot variability , 1992, Neurobiology of Aging.

[68]  W. Jagust,et al.  Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[69]  M. Mattson,et al.  IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  M. Mattson Untangling the pathophysio-chemistry of β-amyloid , 1995, Nature Structural Biology.

[71]  L. Iversen,et al.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[72]  B. Yankner Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[73]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[74]  Brian J Cummings,et al.  Image analysis of β-amyloid load in Alzheimer's disease and relation to dementia severity , 1995, The Lancet.

[75]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.